Varicella vaccine produces an attenuated clinically inapparent varicella infection in susceptible subjects.
The presence of antibodies is accepted as evidence of protection, however, there is no established limit of protection for varicella disease.
Evaluation of pharmacokinetic properties is not required for vaccines.
Non-clinical data reveal no special hazard for humans based on general safety tests performed in animals.
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
